Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
1(20%)
Results Posted
75%(3 trials)

Phase Distribution

Ph phase_2
1
20%
Ph phase_4
3
60%
Ph not_applicable
1
20%

Phase Distribution

0

Early Stage

1

Mid Stage

3

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
1(20.0%)
Phase 4Post-market surveillance
3(60.0%)
N/ANon-phased studies
1(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(4)

Detailed Status

Completed4
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (20.0%)
Phase 43 (60.0%)
N/A1 (20.0%)

Trials by Status

recruiting120%
completed480%

Recent Activity

1 active trials
Showing 5 of 5
completedphase_4

Clinical Application of Simcyp-Guided Doses of Antihypertensive Drugs in Cirrhotic Patients

NCT07397481
recruitingphase_2

Evaluation of the Cardioprotective Effect of Nebivolol on Trastuzumab-Induced Cardiotoxicity in Breast Cancer Patients

NCT07233499
completedphase_4

Open-label inteRventional Clinical Trial to Assess Efficacy and Safety of the exteMporaneous combInation of Nebivolol and Ramipril in hypertenSIve pAtients

NCT06104423
completedphase_4

Effectiveness and Safety of Combination of Nebivolol and Zofenopril in Hypertensive patIents Versus Each Monotherapy

NCT05257148
completednot_applicable

Nebivolol in the Supine Hypertension of Autonomic Failure

NCT01044693

Clinical Trials (5)

Showing 5 of 5 trials
NCT07397481Phase 4

Clinical Application of Simcyp-Guided Doses of Antihypertensive Drugs in Cirrhotic Patients

Completed
NCT07233499Phase 2

Evaluation of the Cardioprotective Effect of Nebivolol on Trastuzumab-Induced Cardiotoxicity in Breast Cancer Patients

Recruiting
NCT06104423Phase 4

Open-label inteRventional Clinical Trial to Assess Efficacy and Safety of the exteMporaneous combInation of Nebivolol and Ramipril in hypertenSIve pAtients

Completed
NCT05257148Phase 4

Effectiveness and Safety of Combination of Nebivolol and Zofenopril in Hypertensive patIents Versus Each Monotherapy

Completed
NCT01044693Not Applicable

Nebivolol in the Supine Hypertension of Autonomic Failure

Completed

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5